Future studies of VEGF or VEGFR inhibitors combined with neurotoxic chemotherapy should prospectively evaluate chemotherapy-induced neuropathy at the same time points, using electrophysiological studies and validated neuropathy severity scales that would provide more accurate information for the evaluation of neuropathy. Here, KDR is linked to neuropathy.